IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT00430963
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
256
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
IncobotulinumtoxinA (Xeomin) (20 Units)
DRUG:
Placebo
Sponsor
Merz Pharmaceuticals GmbH